Pharmacists in Mason, MI Accepting Medicare

11 Pharmacists found. Showing 1 - 11

Janis Lynn Haynes, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 N Cedar St, Mason, MI 48854 Phone: 517-676-4421

Mrs. Amna N Khan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 N Cedar St, Mason, MI 48854 Phone: 517-676-4421

Blaine Kubiak, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 Hull Rd, Mason, MI 48854 Phone: 517-244-1910

Linda Szymborski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 Hull Rd, Mason, MI 48854 Phone: 517-244-1910    Fax: 517-244-1965

Dr. Terrence Thole, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 Hull Rd, Mason, MI 48854 Phone: 517-244-1910    Fax: 517-244-1965

Franz Neubrecht, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3481 Josephine Ln, Mason, MI 48854 Phone: 517-676-5391

Laura Jean Mcgonigal, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 304 S Jefferson St, Mason, MI 48854 Phone: 517-676-9199

Michael Halstead Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 304 S Jefferson St, Mason, MI 48854 Phone: 517-676-9199

Brian Kosier Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 550 Hull Rd, Mason, MI 48854 Phone: 517-244-1910

Francois Vosloo, PHARMD Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 550 Hull Rd, Mason, MI 48854 Phone: 517-244-1910

Dr. Cashell Southwick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 Hull Rd, Mason, MI 48854 Phone: 517-244-1933    Fax: 517-244-1965

News Archive

ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress

ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced initial safety and preliminary anti-tumor activity from the FORWARD II expansion cohort assessing mirvetuximab soravtansine in combination with Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab).

INPC provides early warning of influenza outbreaks and other communicable diseases

The Centers for Disease Control has reported that influenza activity is high across most of the United States. The Indiana Network for Patient Care's ability to track data from physician offices and medical facilities across Indiana provides public health officials in the Hoosier state with early warning of outbreaks of influenza and other communicable diseases in Indiana.

New compound could offer cardio protection during and even after heart attack

Imagine there were a drug that you could take soon after a heart attack that could reduce damage by protecting healthy heart muscle tissue.

FDA approves Keppra (levetiracetam) for epilepsy treatment

UCB has announced that the U.S. Food and Drug Administration (FDA) has approved Keppra (levetiracetam) injection for use as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy.

Inovio Pharmaceuticals proposes 1-for-4 reverse split of common stock

Inovio Pharmaceuticals, Inc. today announced that at the Company's Annual General Meeting held May 22, 2014, the Company's shareholders approved the proposal of a reverse split of the Company's common stock.

Read more Medical News

› Verified 6 days ago